Patient-level characteristics | Total, N = 50,510 | Ever had a HR-HPV DNA test, n = 13,440* |  | Ever received a positive HR-HPVtest result, n = 1792** |  |
---|---|---|---|---|---|
n (%) | n (%) | P a | n (%) | P b | |
Sociodemographics | |||||
 Age at enrollment into NJCEED (years) |  |  | < 0.001 |  | < 0.001 |
  29–39 | 7987 (15.8) | 2457 (18.3) |  | 532 (29.7) |  |
  40–49 | 19,909 (39.4) | 5663 (42.1) |  | 689 (38.4) |  |
   ≥ 50 | 22,614 (44.8) | 5320 (39.6) |  | 571 (31.9) |  |
 Race/ethnicity |  |  | < 0.001 |  | < 0.001 |
  Non-Hispanic White | 12,420 (24.6) | 2706 (20.1) |  | 443 (24.7) |  |
  Non-Hispanic Black | 7716 (15.3) | 1993 (14.8) |  | 247 (13.8) |  |
  Asian/Pacific Islander | 3351 (6.6) | 1060 (7.9) |  | 98 (5.5) |  |
  Hispanic | 27,023 (53.5) | 7681 (57.2) |  | 1004 (56.0) |  |
 Place of birth |  |  | < 0.001 |  | < 0.001 |
  USA | 14,695 (29.1) | 3468 (25.8) |  | 525 (29.3) |  |
  Central and South America | 20,437 (40.5) | 5575 (41.5) |  | 754 (42.1) |  |
  Caribbean | 7266 (14.4) | 2007 (14.9) |  | 261 (14.6) |  |
  Africa | 952 (1.9) | 243 (1.8) |  | 19 (1.1) |  |
  Asia and the Middle East | 3283 (6.5) | 1075 (8.0) |  | 95 (5.3) |  |
  Europe, Russia and Australia and Oceania | 1549 (3.1) | 546 (4.1) |  | 61 (3.4) |  |
  Other countriesc | 2328 (4.6) | 526 (3.9) |  | 77 (4.3) |  |
Cervical cancer screening characteristics | |||||
 Number of cervical screening visits |  |  | < 0.001 |  | < 0.001 |
  1 | 29,872 (59.1) | 7399 (55.1) |  | 842 (47.0) |  |
  2 | 8760 (17.3) | 2488 (18.5) |  | 356 (19.9) |  |
   ≥ 3 | 11,878 (23.5) | 3553 (26.4) |  | 594 (33.1) |  |
 Number of Pap tests |  |  | < 0.001 |  |  |
  0 | 1571 (3.1) | 10 (0.1) |  | 4 (0.2) |  |
  1 | 35,670 (70.6) | 8488 (63.2) |  | 967 (54.0) |  |
  2 | 8347 (16.5) | 2717 (20.2) |  | 379 (21.1) |  |
   ≥ 3 | 4922 (9.7) | 2230 (16.6) |  | 442 (24.7) |  |
 Age at first Pap test (years) |  |  | < 0.001 |  |  |
  29–39 | 7778 (15.9) | 2450 (18.2) |  | 529 (29.6) |  |
  40–49 | 19,291 (39.4) | 5658 (42.1) |  | 688 (38.5) |  |
   ≥ 50 | 21,870 (44.7) | 5322 (39.6) |  | 571 (31.9) |  |
 Number of HPV tests |  |  | < 0.001 |  | < 0.001 |
  0 | 37,070 (73.4) | 0 (0.0) |  | 0 (0.0) |  |
  1 | 11,810 (23.4) | 11,810 (87.9) |  | 1391 (77.6) |  |
  2 | 1386 (2.7) | 1386 (10.3) |  | 306 (17.1) |  |
   ≥ 3 | 244 (0.5) | 244 (1.8) |  | 95 (5.3) |  |
 Age at first HPV test (years) |  |  | – |  | < 0.001 |
  29–39 |  | 2307 (17.2) |  | 514 (28.7) |  |
  40–49 |  | 5461 (40.6) |  | 673 (37.6) |  |
   ≥ 50 |  | 5672 (42.2) |  | 605 (33.8) |  |